{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T18:54:15Z","timestamp":1784228055792,"version":"3.55.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,11,9]],"date-time":"2016-11-09T00:00:00Z","timestamp":1478649600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Bone Miner Metab"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1007\/s00774-016-0792-5","type":"journal-article","created":{"date-parts":[[2016,11,9]],"date-time":"2016-11-09T07:26:48Z","timestamp":1478676408000},"page":"571-580","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Comparison of the effects of denosumab between a native vitamin D combination and an active vitamin D combination in patients with postmenopausal osteoporosis"],"prefix":"10.1007","volume":"35","author":[{"given":"Kosuke","family":"Ebina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Kashii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Hirao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaaki","family":"Noguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kota","family":"Koizumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuma","family":"Kitaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hozo","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Iwahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunori","family":"Tsukamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,9]]},"reference":[{"key":"792_CR1","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","volume":"423","author":"WJ Boyle","year":"2003","unstructured":"Boyle WJ, Simonet WS, Lacey DL (2003) Osteoclast differentiation and activation. Nature 423:337\u2013342","journal-title":"Nature"},{"key":"792_CR2","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1002\/jbmr.1941","volume":"28","author":"M Honma","year":"2013","unstructured":"Honma M, Ikebuchi Y, Kariya Y, Hayashi M, Hayashi N, Aoki S, Suzuki H (2013) RANKL subcellular trafficking and regulatory mechanisms in osteocytes. J Bone Miner Res 28:1936\u20131949","journal-title":"J Bone Miner Res"},{"key":"792_CR3","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s00774-015-0677-z","volume":"34","author":"N Setsu","year":"2016","unstructured":"Setsu N, Kobayashi E, Asano N, Yasui N, Kawamoto H, Kawai A, Horiuchi K (2016) Severe hypercalcemia following denosumab treatment in a juvenile patient. J Bone Miner Metab 34:118\u2013122","journal-title":"J Bone Miner Metab"},{"key":"792_CR4","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1359\/jbmr.0809010","volume":"24","author":"JP Brown","year":"2009","unstructured":"Brown JP, Prince RL, Deal C, Recker RR, Kiel DP, de Gregorio LH, Hadji P, Hofbauer LC, Alvaro-Gracia JM, Wang H, Austin M, Wagman RB, Newmark R, Libanati C, San Martin J, Bone HG (2009) Comparison of the effect of denosumab and alendronate on BMD and biochemical markers of bone turnover in postmenopausal women with low bone mass: a randomized, blinded, phase 3 trial. J Bone Miner Res 24:153\u2013161","journal-title":"J Bone Miner Res"},{"key":"792_CR5","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1097\/AOG.0b013e318291718c","volume":"121","author":"C Recknor","year":"2013","unstructured":"Recknor C, Czerwinski E, Bone HG, Bonnick SL, Binkley N, Palacios S, Moffett A, Siddhanti S, Ferreira I, Ghelani P, Wagman RB, Hall JW, Bolognese MA, Benhamou CL (2013) Denosumab compared with ibandronate in postmenopausal women previously treated with bisphosphonate therapy: a randomized open-label trial. Obstet Gynecol 121:1291\u20131299","journal-title":"Obstet Gynecol"},{"key":"792_CR6","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bone.2013.10.006","volume":"58","author":"C Roux","year":"2014","unstructured":"Roux C, Hofbauer LC, Ho PR, Wark JD, Zillikens MC, Fahrleitner-Pammer A, Hawkins F, Micaelo M, Minisola S, Papaioannou N, Stone M, Ferreira I, Siddhanti S, Wagman RB, Brown JP (2014) Denosumab compared with risedronate in postmenopausal women suboptimally adherent to alendronate therapy: efficacy and safety results from a randomized open-label study. Bone 58:48\u201354","journal-title":"Bone"},{"key":"792_CR7","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1359\/jbmr.090716","volume":"25","author":"DL Kendler","year":"2010","unstructured":"Kendler DL, Roux C, Benhamou CL, Brown JP, Lillestol M, Siddhanti S, Man HS, San Martin J, Bone HG (2010) Effects of denosumab on bone mineral density and bone turnover in postmenopausal women transitioning from alendronate therapy. J Bone Miner Res 25:72\u201381","journal-title":"J Bone Miner Res"},{"key":"792_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-015-0731-x","author":"K Ebina","year":"2016","unstructured":"Ebina K, Hashimoto J, Kashii M, Hirao M, Kaneshiro S, Noguchi T, Tsukamoto Y, Yoshikawa H (2016) The effects of switching daily teriparatide to oral bisphosphonates or denosumab in patients with primary osteoporosis. J Bone Miner Metab. doi: 10.1007\/s00774-015-0731-x","journal-title":"J Bone Miner Metab"},{"key":"792_CR9","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1210\/jc.2013-4175","volume":"99","author":"T Nakamura","year":"2014","unstructured":"Nakamura T, Matsumoto T, Sugimoto T, Hosoi T, Miki T, Gorai I, Yoshikawa H, Tanaka Y, Tanaka S, Sone T, Nakano T, Ito M, Matsui S, Yoneda T, Takami H, Watanabe K, Osakabe T, Shiraki M, Fukunaga M (2014) Clinical Trials Express: fracture risk reduction with denosumab in Japanese postmenopausal women and men with osteoporosis: Denosumab Fracture Intervention Randomized Placebo Controlled Trial (DIRECT). J Clin Endocrinol Metab 99:2599\u20132607","journal-title":"J Clin Endocrinol Metab"},{"key":"792_CR10","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00198-014-2964-2","volume":"26","author":"T Sugimoto","year":"2015","unstructured":"Sugimoto T, Matsumoto T, Hosoi T, Miki T, Gorai I, Yoshikawa H, Tanaka Y, Tanaka S, Fukunaga M, Sone T, Nakano T, Ito M, Matsui S, Yoneda T, Takami H, Watanabe K, Osakabe T, Okubo N, Shiraki M, Nakamura T (2015) Three-year denosumab treatment in postmenopausal Japanese women and men with osteoporosis: results from a 1-year open-label extension of the Denosumab Fracture Intervention Randomized Placebo Controlled Trial (DIRECT). Osteoporos Int 26:765\u2013774","journal-title":"Osteoporos Int"},{"key":"792_CR11","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1007\/s00296-008-0835-x","volume":"29","author":"JD Ringe","year":"2009","unstructured":"Ringe JD, Schacht E (2009) Potential of alfacalcidol for reducing increased risk of falls and fractures. Rheumatol Int 29:1177\u20131185","journal-title":"Rheumatol Int"},{"key":"792_CR12","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s00223-008-9102-0","volume":"82","author":"F Richy","year":"2008","unstructured":"Richy F, Dukas L, Schacht E (2008) Differential effects of D-hormone analogs and native vitamin D on the risk of falls: a comparative meta-analysis. Calcif Tissue Int 82:102\u2013107","journal-title":"Calcif Tissue Int"},{"key":"792_CR13","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s00223-004-0005-4","volume":"76","author":"F Richy","year":"2005","unstructured":"Richy F, Schacht E, Bruyere O, Ethgen O, Gourlay M, Reginster JY (2005) Vitamin D analogs versus native vitamin D in preventing bone loss and osteoporosis-related fractures: a comparative meta-analysis. Calcif Tissue Int 76:176\u2013186","journal-title":"Calcif Tissue Int"},{"key":"792_CR14","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00296-006-0288-z","volume":"27","author":"JD Ringe","year":"2007","unstructured":"Ringe JD, Farahmand P, Schacht E, Rozehnal A (2007) Superiority of a combined treatment of alendronate and alfacalcidol compared to the combination of alendronate and plain vitamin D or alfacalcidol alone in established postmenopausal or male osteoporosis (AAC-Trial). Rheumatol Int 27:425\u2013434","journal-title":"Rheumatol Int"},{"key":"792_CR15","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00296-007-0422-6","volume":"28","author":"JD Ringe","year":"2007","unstructured":"Ringe JD, Schacht E (2007) Improving the outcome of established therapies for osteoporosis by adding the active D-hormone analog alfacalcidol. Rheumatol Int 28:103\u2013111","journal-title":"Rheumatol Int"},{"key":"792_CR16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11657-012-0109-9","volume":"7","author":"H Orimo","year":"2012","unstructured":"Orimo H, Nakamura T, Hosoi T, Iki M, Uenishi K, Endo N, Ohta H, Shiraki M, Sugimoto T, Suzuki T, Soen S, Nishizawa Y, Hagino H, Fukunaga M, Fujiwara S (2012) Japanese 2011 guidelines for prevention and treatment of osteoporosis\u2013executive summary. Arch Osteoporos 7:3\u201320","journal-title":"Arch Osteoporos"},{"key":"792_CR17","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1007\/s00198-014-2819-x","volume":"25","author":"K Ebina","year":"2014","unstructured":"Ebina K, Hashimoto J, Shi K, Kashii M, Hirao M, Yoshikawa H (2014) Comparison of the effect of 18-month daily teriparatide administration on patients with rheumatoid arthritis and postmenopausal osteoporosis patients. Osteoporos Int 25:2755\u20132765","journal-title":"Osteoporos Int"},{"key":"792_CR18","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00774-015-0710-2","volume":"34","author":"K Ebina","year":"2015","unstructured":"Ebina K, Noguchi T, Hirao M, Kaneshiro S, Tsukamoto Y, Yoshikawa H (2015) Comparison of the effects of 12\u00a0months of monthly minodronate monotherapy and monthly minodronate combination therapy with vitamin K or eldecalcitol in patients with primary osteoporosis. J Bone Miner Metab 34:243\u2013250","journal-title":"J Bone Miner Metab"},{"key":"792_CR19","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.3109\/s10165-012-0789-4","volume":"23","author":"K Ebina","year":"2013","unstructured":"Ebina K, Shi K, Hirao M, Kaneshiro S, Morimoto T, Koizumi K, Yoshikawa H, Hashimoto J (2013) Vitamin K2 administration is associated with decreased disease activity in patients with rheumatoid arthritis. Mod Rheumatol 23:1001\u20131007","journal-title":"Mod Rheumatol"},{"key":"792_CR20","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1007\/s00198-014-2993-x","volume":"26","author":"K Ebina","year":"2014","unstructured":"Ebina K, Hashimoto J, Shi K, Kashii M, Hirao M, Yoshikawa H (2014) Undercarboxylated osteocalcin may be an attractive marker of teriparatide treatment in RA patients: response to Mokuda. Osteoporos Int 26:1445","journal-title":"Osteoporos Int"},{"key":"792_CR21","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nrendo.2012.201","volume":"9","author":"SL Booth","year":"2013","unstructured":"Booth SL, Centi A, Smith SR, Gundberg C (2013) The role of osteocalcin in human glucose metabolism: marker or mediator? Nat Rev Endocrinol 9:43\u201355","journal-title":"Nat Rev Endocrinol"},{"key":"792_CR22","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1002\/jbmr.2480","volume":"30","author":"MS Ominsky","year":"2015","unstructured":"Ominsky MS, Libanati C, Niu QT, Boyce RW, Kostenuik PJ, Wagman RB, Baron R, Dempster DW (2015) Sustained modeling-based done formation during adulthood in cynomolgus monkeys may contribute to continuous BMD gains with denosumab. J Bone Miner Res 30:1280\u20131289","journal-title":"J Bone Miner Res"},{"key":"792_CR23","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1001\/jama.291.16.1999","volume":"291","author":"HA Bischoff-Ferrari","year":"2004","unstructured":"Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC, Staehelin HB, Bazemore MG, Zee RY, Wong JB (2004) Effect of vitamin D on falls: a meta-analysis. JAMA 291:1999\u20132006","journal-title":"JAMA"},{"key":"792_CR24","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s00198-011-1659-1","volume":"23","author":"A Arabi","year":"2012","unstructured":"Arabi A, Baddoura R, El-Rassi R, El-Hajj Fuleihan G (2012) PTH level but not 25 (OH) vitamin D level predicts bone loss rates in the elderly. Osteoporos Int 23:971\u2013980","journal-title":"Osteoporos Int"},{"key":"792_CR25","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","volume":"344","author":"RM Neer","year":"2001","unstructured":"Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, Hodsman AB, Eriksen EF, Ish-Shalom S, Genant HK, Wang O, Mitlak BH (2001) Effect of parathyroid hormone (1\u201334) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344:1434\u20131441","journal-title":"N Engl J Med"},{"key":"792_CR26","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/ajcn\/65.1.67","volume":"65","author":"B Dawson-Hughes","year":"1997","unstructured":"Dawson-Hughes B, Harris SS, Dallal GE (1997) Plasma calcidiol, season, and serum parathyroid hormone concentrations in healthy elderly men and women. Am J Clin Nutr 65:67\u201371","journal-title":"Am J Clin Nutr"},{"key":"792_CR27","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.1210\/jc.2009-1294","volume":"95","author":"J Aloia","year":"2010","unstructured":"Aloia J, Bojadzievski T, Yusupov E, Shahzad G, Pollack S, Mikhail M, Yeh J (2010) The relative influence of calcium intake and vitamin D status on serum parathyroid hormone and bone turnover biomarkers in a double-blind, placebo-controlled parallel group, longitudinal factorial design. J Clin Endocrinol Metab 95:3216\u20133224","journal-title":"J Clin Endocrinol Metab"},{"key":"792_CR28","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1530\/EJE-11-0184","volume":"165","author":"A Chaitou","year":"2011","unstructured":"Chaitou A, Boutroy S, Vilayphiou N, Varennes A, Richard M, Blaizot S, Munoz F, Delmas PD, Goudable J, Chapurlat R, Szulc P (2011) Association of bone microarchitecture with parathyroid hormone concentration and calcium intake in men: the STRAMBO study. Eur J Endocrinol 165:151\u2013159","journal-title":"Eur J Endocrinol"},{"key":"792_CR29","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/jbmr.2401","volume":"30","author":"PJ Kostenuik","year":"2015","unstructured":"Kostenuik PJ, Smith SY, Samadfam R, Jolette J, Zhou L, Ominsky MS (2015) Effects of denosumab, alendronate, or denosumab following alendronate on bone turnover, calcium homeostasis, bone mass and bone strength in ovariectomized cynomolgus monkeys. J Bone Miner Res 30:657\u2013669","journal-title":"J Bone Miner Res"},{"key":"792_CR30","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/j.1532-5415.2007.01161.x","volume":"55","author":"A Barone","year":"2007","unstructured":"Barone A, Giusti A, Pioli G, Girasole G, Razzano M, Pizzonia M, Palummeri E, Bianchi G (2007) Secondary hyperparathyroidism due to hypovitaminosis D affects bone mineral density response to alendronate in elderly women with osteoporosis: a randomized controlled trial. J Am Geriatr Soc 55:752\u2013757","journal-title":"J Am Geriatr Soc"},{"key":"792_CR31","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1507\/endocrj.45.191","volume":"45","author":"M Shiraki","year":"1998","unstructured":"Shiraki M, Kushida K, Fukunaga M, Kishimoto H, Kaneda K, Minaguchi H, Inoue T, Tomita A, Nagata Y, Nakashima M, Orimo H (1998) A placebo-controlled, single-blind study to determine the appropriate alendronate dosage in postmenopausal Japanese patients with osteoporosis. Endocr J 45:191\u2013201","journal-title":"Endocr J"},{"key":"792_CR32","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jsbmb.2012.10.004","volume":"136","author":"H Saito","year":"2013","unstructured":"Saito H, Takeda S, Amizuka N (2013) Eldecalcitol and calcitriol stimulates \u2018bone minimodeling\u2019, focal bone formation without prior bone resorption, in rat trabecular bone. J Steroid Biochem Mol Biol 136:178\u2013182","journal-title":"J Steroid Biochem Mol Biol"},{"key":"792_CR33","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1210\/endo.136.8.7628403","volume":"136","author":"H Dobnig","year":"1995","unstructured":"Dobnig H, Turner RT (1995) Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells. Endocrinology 136:3632\u20133638","journal-title":"Endocrinology"},{"key":"792_CR34","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00223-007-9086-1","volume":"82","author":"H Chen","year":"2008","unstructured":"Chen H, Tian X, Liu X, Setterberg RB, Li M, Jee WS (2008) Alfacalcidol-stimulated focal bone formation on the cancellous surface and increased bone formation on the periosteal surface of the lumbar vertebrae of adult female rats. Calcif Tissue Int 82:127\u2013136","journal-title":"Calcif Tissue Int"},{"key":"792_CR35","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00774-008-0854-4","volume":"26","author":"XQ Liu","year":"2008","unstructured":"Liu XQ, Chen HY, Tian XY, Setterberg RB, Li M, Jee WS (2008) Alfacalcidol treatment increases bone mass from anticatabolic and anabolic effects on cancellous and cortical bone in intact female rats. J Bone Miner Metab 26:425\u2013435","journal-title":"J Bone Miner Metab"},{"key":"792_CR36","doi-asserted-by":"publisher","unstructured":"Mallya SM, Corrado KR, Saria EA, Yuan FF, Tran HQ, Saucier K, Atti E, Tetradis S, Arnold A (2016) Modeling vitamin D insufficiency and moderate deficiency in adult mice via dietary cholecalciferol restriction. Endocr Res. doi: 10.3109\/07435800.2016.1141937","DOI":"10.3109\/07435800.2016.1141937"},{"key":"792_CR37","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/jbmr.251","volume":"26","author":"R Eastell","year":"2011","unstructured":"Eastell R, Christiansen C, Grauer A, Kutilek S, Libanati C, McClung MR, Reid IR, Resch H, Siris E, Uebelhart D, Wang A, Weryha G, Cummings SR (2011) Effects of denosumab on bone turnover markers in postmenopausal osteoporosis. J Bone Miner Res 26:530\u2013537","journal-title":"J Bone Miner Res"}],"container-title":["Journal of Bone and Mineral Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00774-016-0792-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-016-0792-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-016-0792-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,15]],"date-time":"2019-09-15T07:53:02Z","timestamp":1568533982000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00774-016-0792-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,9]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["792"],"URL":"https:\/\/doi.org\/10.1007\/s00774-016-0792-5","relation":{},"ISSN":["0914-8779","1435-5604"],"issn-type":[{"value":"0914-8779","type":"print"},{"value":"1435-5604","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,9]]}}}